[Federal Register Volume 87, Number 168 (Wednesday, August 31, 2022)]
[Notices]
[Page 53505]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-18793]


=======================================================================
-----------------------------------------------------------------------

NATIONAL AERONAUTICS AND SPACE ADMINISTRATION

[Notice (22-063)]


Notice of Intent To Grant an Exclusive, Co-Exclusive or Partially 
Exclusive Patent License

AGENCY: National Aeronautics and Space Administration.

ACTION: Notice of Intent to Grant exclusive, co-exclusive or partially 
exclusive patent license.

-----------------------------------------------------------------------

SUMMARY: NASA hereby gives notice of its intent to grant an exclusive, 
co-exclusive or partially exclusive patent license to practice the 
inventions described and claimed in the patents and/or patent 
applications listed in SUPPLEMENTARY INFORMATION below.

DATES: The prospective exclusive, co-exclusive or partially exclusive 
license may be granted unless NASA receives written objections 
including evidence and argument, no later than September 15, 2022 that 
establish that the grant of the license would not be consistent with 
the requirements regarding the licensing of federally owned inventions 
as set forth in the Bayh-Dole Act and implementing regulations. 
Competing applications completed and received by NASA no later than 
September 15, 2022 will also be treated as objections to the grant of 
the contemplated exclusive, co-exclusive or partially exclusive 
license. Objections submitted in response to this notice will not be 
made available to the public for inspection and, to the extent 
permitted by law, will not be released under the Freedom of Information 
Act.
    Objections and Further Information: Written objections relating to 
the prospective license or requests for further information may be 
submitted to Agency Counsel for Intellectual Property, NASA 
Headquarters at Email: [email protected]. Questions may be 
directed to Phone: (202) 358-3437.

SUPPLEMENTARY INFORMATION: NASA intends to grant an exclusive, co-
exclusive, or partially exclusive patent license in the United States 
to practice the inventions described and claimed in: U.S. Patent 
10,566,089 entitled, ``Nanosensor Array For Medical Diagnoses,'' to 
Agscent USA Inc., having its principal place of business in Denver, CO. 
The fields of use may be limited. NASA has not yet made a final 
determination to grant the requested license and may deny the requested 
license even if no objections are submitted within the comment period.
    This notice of intent to grant an exclusive, co-exclusive or 
partially exclusive patent license is issued in accordance with 35 
U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i). The patent rights in these 
inventions have been assigned to the United States of America as 
represented by the Administrator of the National Aeronautics and Space 
Administration. The prospective license will comply with the 
requirements of 35 U.S.C. 209 and 37 CFR 404.7.
    Information about other NASA inventions available for licensing can 
be found online at http://technology.nasa.gov.

Helen M. Galus,
Agency Counsel for Intellectual Property.
[FR Doc. 2022-18793 Filed 8-30-22; 8:45 am]
BILLING CODE 7510-13-P